146 related articles for article (PubMed ID: 37747399)
1. A wedge is still better than stereotactic body radiation therapy in the national cancer database.
Odeh AM; Perez-Tamayo RA; Abdelsattar ZM
J Thorac Cardiovasc Surg; 2024 Apr; 167(4):e100-e101. PubMed ID: 37747399
[No Abstract] [Full Text] [Related]
2. A national analysis of wedge resection versus stereotactic body radiation therapy for stage IA non-small cell lung cancer.
Yerokun BA; Yang CJ; Gulack BC; Li X; Mulvihill MS; Gu L; Wang X; Harpole DH; D'Amico TA; Berry MF; Hartwig MG
J Thorac Cardiovasc Surg; 2017 Aug; 154(2):675-686.e4. PubMed ID: 28461054
[TBL] [Abstract][Full Text] [Related]
3. Surgical quality of wedge resection affects overall survival in patients with early stage non-small cell lung cancer.
Ajmani GS; Wang CH; Kim KW; Howington JA; Krantz SB
J Thorac Cardiovasc Surg; 2018 Jul; 156(1):380-391.e2. PubMed ID: 29680711
[TBL] [Abstract][Full Text] [Related]
4. The National Surgical Quality Improvement Program risk calculator does not adequately stratify risk for patients with clinical stage I non-small cell lung cancer.
Samson P; Robinson CG; Bradley J; Lee A; Broderick S; Kreisel D; Krupnick AS; Patterson GA; Puri V; Meyers BF; Crabtree T
J Thorac Cardiovasc Surg; 2016 Mar; 151(3):697-705.e1. PubMed ID: 26410001
[TBL] [Abstract][Full Text] [Related]
5. Sublobar/wedge resection or stereotactic body radiation therapy for stage I marginally operable non-small-cell lung cancer.
Suppiah S; Linden P; Robke J; Schroeder C; Yao M; Machtay M; Lo SS
Expert Rev Anticancer Ther; 2012 Nov; 12(11):1375-7. PubMed ID: 23249103
[No Abstract] [Full Text] [Related]
6. Stereotactic Body Radiotherapy and Ablative Therapies for Lung Cancer.
Abbas G; Danish A; Krasna MJ
Surg Oncol Clin N Am; 2016 Jul; 25(3):553-66. PubMed ID: 27261915
[TBL] [Abstract][Full Text] [Related]
7. Dose and Fractionation in Stereotactic Body Radiation Therapy for Stage I Non-Small Cell Lung Cancer: Lessons Learned and Where Do We Go Next?
Guckenberger M
Int J Radiat Oncol Biol Phys; 2015 Nov; 93(4):765-8. PubMed ID: 26530744
[No Abstract] [Full Text] [Related]
8. [Stereotactic body radiation therapy for early non-small cell lung cancer].
Zhang HQ; Li MH; Yu JM
Zhonghua Zhong Liu Za Zhi; 2011 Aug; 33(8):561-3. PubMed ID: 22325212
[No Abstract] [Full Text] [Related]
9. Stereotactic body radiation therapy (stereotactic ablative radiotherapy) for stage I non-small cell lung cancer--updates of radiobiology, techniques, and clinical outcomes.
Hadziahmetovic M; Loo BW; Timmerman RD; Mayr NA; Wang JZ; Huang Z; Grecula JC; Lo SS
Discov Med; 2010 May; 9(48):411-7. PubMed ID: 20515609
[TBL] [Abstract][Full Text] [Related]
10. Commentary: Surgery versus stereotactic body radiation therapy for patients with renal dysfunction and non-small cell lung cancer: The answer is still not clear.
Chang SH
J Thorac Cardiovasc Surg; 2022 Jul; 164(1):240-241. PubMed ID: 34865839
[No Abstract] [Full Text] [Related]
11. Is There Still a Role for Stereotactic Body Radiation Therapy in Early-Stage Lung Cancer?
Deng HY; Tang X
Ann Thorac Surg; 2021 Mar; 111(3):1092-1093. PubMed ID: 32717234
[No Abstract] [Full Text] [Related]
12. Stereotactic body radiation therapy versus surgical resection for stage I non-small cell lung cancer.
Crabtree TD; Denlinger CE; Meyers BF; El Naqa I; Zoole J; Krupnick AS; Kreisel D; Patterson GA; Bradley JD
J Thorac Cardiovasc Surg; 2010 Aug; 140(2):377-86. PubMed ID: 20400121
[TBL] [Abstract][Full Text] [Related]
13. Size matters: a comparison of T1 and T2 peripheral non-small-cell lung cancers treated with stereotactic body radiation therapy (SBRT).
Dunlap NE; Larner JM; Read PW; Kozower BD; Lau CL; Sheng K; Jones DR
J Thorac Cardiovasc Surg; 2010 Sep; 140(3):583-9. PubMed ID: 20478576
[TBL] [Abstract][Full Text] [Related]
14. Treatment Outcomes in Stage I Lung Cancer: A Comparison of Surgery and Stereotactic Body Radiation Therapy.
Poullis M
J Thorac Oncol; 2016 May; 11(5):e64-e65. PubMed ID: 27131296
[No Abstract] [Full Text] [Related]
15. In Response to Treatment Outcomes in Stage I Lung Cancer: A Comparison of Surgery and Stereotactic Body Radiation Therapy.
Puri V; Robinson CG
J Thorac Oncol; 2016 May; 11(5):e65-e66. PubMed ID: 27131297
[No Abstract] [Full Text] [Related]
16. Secondary Brain Neoplasm after Stereotactic Radiosurgery in Patients with Metastatic Non-small Cell Lung Cancer.
Nukaga S; Naoki K; Yasuda H; Kawada I; Ohara K; Soejima K; Betsuyaku T
Intern Med; 2018 Aug; 57(16):2383-2387. PubMed ID: 29526937
[TBL] [Abstract][Full Text] [Related]
17. Stereotactic body radiation therapy for inoperable lung cancer.
Rusthoven KE; Pugh TJ
JAMA; 2010 Jun; 303(23):2354-5; author reply 2355. PubMed ID: 20551403
[No Abstract] [Full Text] [Related]
18. [Stereotactic radiotherapy for stage I and II lung cancer: a study of 33 patients].
Champeaux-Orange E; Wachter T; Bouscayrol H; Barillot I
Cancer Radiother; 2011 Jun; 15(3):192-6. PubMed ID: 21330178
[TBL] [Abstract][Full Text] [Related]
19. Dose escalation, not "new biology," can account for the efficacy of stereotactic body radiation therapy with non-small cell lung cancer.
Brown JM; Brenner DJ; Carlson DJ
Int J Radiat Oncol Biol Phys; 2013 Apr; 85(5):1159-60. PubMed ID: 23517805
[No Abstract] [Full Text] [Related]
20. Extracranial stereotactic body radiotherapy for stage I non-small cell lung cancer: still investigational or standard of care?
Ball D
J Thorac Oncol; 2008 Nov; 3(11):1209-10. PubMed ID: 18978553
[No Abstract] [Full Text] [Related]
[Next] [New Search]
